Novo Nordisk Inc and Novo Nordisk A/S v Viatris Inc and Mylan Pharmaceuticals, 1:23-cv-00101 and Novo Nordisk Inc and Novo Nordisk A/S v Sun Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries, Inc, 1:23-cv-01459 17 The drop in patent filings observed in 2023 may reflect several factors
10.1111/j.1440-1754.1982.tb01978.x Aust Paediatr J
Obesity is a chronic disease, and when using medications for treatment, they are intended for long-term use just as with other chronic diseases, she said
They can assess whether a replacement is prudent and help you troubleshoot storage barriers that might affect future shipments
Computer-aided recognition and assessment of a porous bioelastomer on ultrasound images for regenerative medicine applications
In the quest for brighter, fairer skin, many individuals are turning to skin-whitening capsules as a solution to enhance their complexion